368 Index Name Paper ref. Name Paper ref. Ssen, C Thu 101 Ssen, U Wed 229, Wed 230, Wed 282, Wed 281, Thu 222, Wed 221, Wed 240, Wed 284, Wed 225, Mon 403, Wed 241, Tue 161, Thu 259 Ssick, A Wed 126 Syi, M FC16.2.6 Simpson, C Wed 137 Simpson, J Mon 238, Tue 364 Simpson, P Thu 030 Sindrup, S FC13.5.5 Sindrup, SH Mon 090 Singer, D Mon 353, Mon 352 Singer, W FC17.2.2 Singewald, N W33.5 Singh, G FC01.3.6 Singh, KK Mon 028 Singh, MF Wed 125 Singh, N Wed 294 Singh, PDA Wed 335 Singh, S FC01.2.6, Mon 169 Singh, TG FC09.5.5 Singh, V Mon 028 Sinha, BN Tue 194 Sinha, RR FC14.3.3 Sinha, S Wed 294 Sinha, SK Thu 120 Sinnayah, P Wed 257 Siow, R Thu 197 Sipetic, T W34.3 Sirirugsa, P Wed 374 Sissoeff, L Mon 469 Sit, A SM Thu 255 Siuni, L Tue 133 Sizova, Z FC13.4.6 Sjögren, B Thu 065 Sjöqvist, F FC01.1.2 Skaddan, M Tue 372 Skandali, N Thu 431 Skapare, Elina Tue 141 Skeberdis, VA Thu 023 Skene, K Tue 232 Skiba, M Thu 242 Skogastierna, C Wed 183, Wed 176, Thu 256 Skomedal, T Tue 143 Skorobogatova, TA Tue 179 Skotnikov, A Tue 267 Skougaard, K Tue 395 Skov Paulsen, M Wed 160 Skovsted, GF Thu 066 Skrbic, R Tue 237 Skvrce, NM Tue 121 Sladic, H Wed 004 Sladkova, M Mon 148 Slavic, M Thu 329, Thu 318, Tue 122 Slifstein, M FC17.1.3 Slikker, W Wed 150 Slinger, E Wed 086 Slizova, D Tue 125 Smajilovic, S FC11.5.1 Smetana, J Tue 056 Smetanova, L Tue 056 Smid, S FC16.3.7 Smidt, K FC05.4.6 Smit, M Wed 086, Thu 085, Thu 060 Smith, A Thu 019, Thu 020 Smith, J FC05.3.6 Smith, JAM Thu 069 Smith, MA Mon 443 Smits, JFM Mon 212, Wed 085 Snape, W FC14.2.5 Snead, A Thu 067 Snopkova, M Mon 219 Snutch, TP FC03.2.1 Snyder, R Thu 021 Snyman, J FC14.5.5 So, SC Thu 341 Soares de Lima, T Thu 353 Soares-da-Silva, P Thu 169, Mon 383 Sobey, CG Mon 305 Sobey, C FC15.1.4 Sobiesiak, AJ Tue 180 Soboloff, J FC12.2.5 Sobor, M Thu 192 Sobotka, L Tue 222, Tue 421 Soengas, I Mon 080 Soeter, RP Mon 400 Søgaard, B Thu 427 Sokol, G Tue 107 Sokova, E Tue 057 Solati, J Wed 012 Soler, D Thu 002 Solís-Herruzo, JL Tue 123 Solito, E FC15.1.5 Solntseva, E Thu 417 Soltani, N Tue 058 Sommet, A Tue 104 Somogyi, A Wed 113 Somogyi, A W16.4 Son, H Tue 349, Mon 033, Thu 418 Son, HK Mon 013 Søndergaard, J Wed 160 Sonderskov, K Thu 101 Sone, S Wed 278 Soner, BC Tue 200 Song, H Tue 419 Song, J Mon 434 Song, J-G Wed 367 Song, J-S Mon 158 Song, R FC14.5.4 Sonmez, A Wed 357 Sonnenberg, J Tue 210 Sonnenberg, S Tue 115 Sordi, R Wed 097 Sørensen, G FC02.3.6 Sørensen, JB Tue 480 Sørensen, L Tue 065 Sørensen, U FC06.3.5 Soriano, FG Wed 202, Wed 204, Wed 203, Mon 257 Soriano, G Tue 123 Soriano-Ursúa, MA. Tue 195 Sortino, MA Wed 400 Sotomayor-Zarate, R Wed 169, Thu 187 Soto-Núñez, M Tue 431 Soubret, A Tue 196 Souccar, C Thu 355
Name Paper ref. Name Paper ref. Soukasem, S Thu 361 Souki, H Tue 457 Soukup, O Tue 448 Soultanov, V Wed 347 Sousa, J Mon 383, Tue 407 Sousa, PCP Thu 374 Sousa, PJC Wed 341, Wed 340, Wed 342 Soussi, F Wed 244 Souto, F Mon 275 Souza, CM Wed 302 Souza, CR Wed 144 Souza, D W31.4 Souza, G FC03.1.5 Souza, HP Wed 202 Souza, L Thu 068 Souza, MHLP Tue 255 Souza, WA Tue 101, Mon 010 Sowunmi, A YI.09 Soydan, G Wed 253 Soydan, Ö Tue 018 Soylar, M Wed 357 Spanagel, R FC14.2.1 Spasic, M Thu 329, Tue 122, Thu 318, Wed 387 Spasojevic, I Wed 387 Spedding, M Tue 479, Wed 072 Speers, J Thu 410 Speerschneider, T Thu 058 Spence, JD Thu 257 Sperlagh, B Mon 460 Sperlágh, B W19.2 Spiers, JP Thu 442 Spijkers, L Thu 258 Spila, B Tue 022 Spiliopoulos, A Mon 143 Spiller, F Mon 275 Spina, D Mon 287 Spina, E Thu 419 Sri Ranganathan, S FC10.2.3 Srichunrasamia, C Tue 127 Sritarab, P Tue 127 Sriwichai, S Tue 090 Staab, A FC07.3.1 Staahl, C W12.5 Staehler, G Mon 245 Staels, B FC18.2.2 Stamer, D Thu 088 Stamou, D Thu 026 Stancic, E Mon 395 Stang, P FC04.2.2 Stanimirovic, B W34.3 Stanimirovic, V W34.3, W34.5 Stanimirovic, VV Wed 435 Stanke, F Tue 268 Stankevicius, E Thu 222, Mon 403, Wed 241, Thu 259 Stanojevic, Z Wed 436 Stanovnik, L Wed 153 Stappen, RK Tue 099 Starodubtzev, A Thu 114 Stasch, J-P FC15.4.1 Stavreva, D FC18.4.2 Steardo, L Tue 465, FC18.4.6 Steensland, P FC14.2.3 Selli, F Wed 442, Mon 382 Sescu, C Tue 134 Steffenhagen, V Tue 210 Stein, D Thu 428 Steinfeld, T Thu 069 Stender, S FC13.3.6 Steneker, I W10.1 Stephens, C Tue 123, Wed 109 Stephens, TD FC04.4.1 Sterin-Prync, A Mon 280 Stern, A Tue 226 Stetinova, V Tue 056 Stevens, L Tue 269 Stevic, S Wed 436 Stewart, D Tue 109 Stewart, AG Thu 393 Stichele, RV Mon 129 Stief, CG FC08.3.5, Mon 247 Stiglmayr, J Tue 214, Thu 354 Stilinovic, N Mon 115 Stilinovic, N Tue 454 Stiller, C-O W05.4 Stoddart, ES Mon 394 Stodulka, P Mon 075, Tue 448 Stoiljkovic, M Thu 070, Stojakovic, N Tue 237 Stojanovic, R Tue 013, Wed 009 Stojanovic, Z Wed 009 Stojiljkovic, M W34.3, Stojiljkovic, MP W34.5 Stojiljkovic, N Thu 070 Stokland, O Wed 139 Stolakis, V Thu 431 Tue 381 Stoltenberg, M Tue 359, Tue 248, Mon 320 Stoop, JE Tue 096 Stosic-Grujicic, S FC16.3.6 Stove, V Mon 365, Tue 306 Strateny, K Tue 113 Strauss, L Mon 215 Street, JM Thu 420, Tue 270 Streng, T Thu 052, Thu 071 Strnad, M Thu 118 Strojil, Jan Tue 124 Strømgaard, K Tue 053, Thu 037, Tue 080, Thu 026, Tue 065 Struijk, JJ Tue 303 Struijker-Boudier, H AJ Mon 212, Thu 221 Stubbs, S FC06.4.5 Studena, S Tue 125 Stürmer, Til FC04.1.3 Stützer, H Thu 018 Stuhr-Hansen, N YI.10 Sturkenboom, M FC04.4.5, FC04.2.6, FC04.4.6, Mon 140, FC04.3.6 Sturmer, T FC04.1.4 Stys, PK Tue 085 Su, D-F PL22, Mon 330, Thu 210, W04.1.2 Su, F Tue 403 Su, MJ Mon 220 Su, M-W Tue 393 Su, R-B Tue 083, Thu 171, FC14.5.4 Su, X Tue 401 Index 369
- Page 1:
of basic and clinical pharmacology
- Page 4 and 5:
Congress patron 2 HRH Crown Princes
- Page 6 and 7:
Congress President Kim Brøsen Secr
- Page 8 and 9:
General information Registration &
- Page 10 and 11:
Banks, currency & credit cards The
- Page 12 and 13:
Information to presenters ■ The a
- Page 14 and 15:
Hotel Bella Center Copenhagen Groun
- Page 16 and 17:
Programme at a glance Time Hall A2
- Page 18 and 19:
16 General events General events Op
- Page 20 and 21:
Programme outline Plenary lectures
- Page 22 and 23:
FC10 Drugs for half the world: Paed
- Page 24 and 25:
Tue 12:45 W13 Workshop: Novel perip
- Page 26 and 27:
W01 Pharmacology of adrenoceptors:
- Page 28 and 29:
W02 Symposium on advances in GI pha
- Page 30 and 31:
W04 Symposium: Antioxidants as ther
- Page 32 and 33:
Plenary lectures PL01 Plenary lectu
- Page 34 and 35:
FC02 Transmembrane transport: Persp
- Page 36 and 37:
FC04 Pharmacoepidemiology, current
- Page 38 and 39:
FC06 The heart gone wrong: Stabiliz
- Page 40 and 41:
FC09 Inflammation and immunopharmac
- Page 42 and 43:
W02 Symposium on advances in GI pha
- Page 44 and 45:
SS01 Sponsored symposium Sponsored
- Page 46 and 47:
W06 Workshop. Effect of disease on
- Page 48 and 49:
W08 Workshop. Identifying targets f
- Page 50 and 51:
W10 Workshop. Innovative Medicines
- Page 52 and 53:
FC01 Clinical pharmacology in the e
- Page 54 and 55:
FC03 Ion channels in analgesia and
- Page 56 and 57:
FC05 Translational science in the m
- Page 58 and 59:
FC06 The heart gone wrong: Stabiliz
- Page 60 and 61:
FC08 Development in the treatment o
- Page 62 and 63:
Plenary lectures PL04 Plenary lectu
- Page 64 and 65:
FC01 Clinical pharmacology in the e
- Page 66 and 67:
FC03 Ion channels in analgesia and
- Page 68 and 69:
FC05 Translational science in the m
- Page 70 and 71:
FC07 Simulation and data modelling
- Page 72 and 73:
FC09 Inflammation and immunopharmac
- Page 74 and 75:
W12 Workshop. Experimental pain met
- Page 76 and 77:
W14 Workshop. Translating the human
- Page 78 and 79:
W15 Workshop. The IUPHAR initiative
- Page 80 and 81:
W17 Workshop. Standards for PhD Edu
- Page 82 and 83:
W19 Workshop. Influence of degenera
- Page 84 and 85:
FC02 Transmembrane transport: Persp
- Page 86 and 87:
FC04 Pharmacoepidemiology, current
- Page 88 and 89:
FC06 The heart gone wrong: Stabiliz
- Page 90 and 91:
FC08 Development in the treatment o
- Page 92 and 93:
PL10 ASPET Plenary Lecture Chair: T
- Page 94 and 95:
FC10 Drugs for half the world: Paed
- Page 96 and 97:
FC12 Ion channelopathies: New windo
- Page 98 and 99:
FC14 Addiction and doping: Neurobio
- Page 100 and 101:
FC17 New approaches and targets in
- Page 102 and 103:
W04 Symposium: Antioxidants as ther
- Page 104 and 105:
W21 Workshop. Inflammation - here,
- Page 106 and 107:
W23 Workshop. Applying pharmacogeno
- Page 108 and 109:
W25 Workshop. High science in the l
- Page 110 and 111:
W27 Workshop. Approaches to medicin
- Page 112 and 113:
FC11 G protein-coupled 7TM receptor
- Page 114 and 115:
FC13 Maximising benefits and minimi
- Page 116 and 117:
FC15 Endothelium in Health and dise
- Page 118 and 119:
FC17 New approaches and targets in
- Page 120 and 121:
FC18 Nuclear receptor targets for t
- Page 122 and 123:
PL16 Plenary Lecture Supported by a
- Page 124 and 125:
FC11 G protein-coupled 7TM receptor
- Page 126 and 127:
FC13 Maximising benefits and minimi
- Page 128 and 129:
FC15 Endothelium in Health and dise
- Page 130 and 131:
FC17 New approaches and targets in
- Page 132 and 133:
W28 Workshop. The Boehringer-Ingelh
- Page 134 and 135:
W30 Workshop. Is eNOS still a valid
- Page 136 and 137:
W32 Workshop. The good, the bad and
- Page 138 and 139:
W34 Workshop. State-of-the-art of b
- Page 140 and 141:
FC10 Drugs for half the world: Pedi
- Page 142 and 143:
FC12 Ion channelopathies: New windo
- Page 144 and 145:
FC14 Addiction and doping: Neurobio
- Page 146 and 147:
FC16 Natural products: Past and fut
- Page 148 and 149:
FC18 Nuclear receptor targets for t
- Page 150 and 151:
PL22 Plenary Lecture Chair: Zhi-Bin
- Page 152 and 153:
FC11 G protein-coupled 7TM receptor
- Page 154 and 155:
FC13 Maximising benefits and minimi
- Page 156 and 157:
FC15 Endothelium in health and dise
- Page 158 and 159:
FC17 New approaches and targets in
- Page 160 and 161:
158
- Page 162 and 163:
FC01 Clinical pharmacology in the e
- Page 164 and 165:
FC01 Clinical pharmacology in the e
- Page 166 and 167:
FC02 Transmembrane transport: Persp
- Page 168 and 169:
FC03 Ion channels in analgesia and
- Page 170 and 171:
W12 Experimental pain methods in de
- Page 172 and 173:
FC04 Pharmacoepidemiology, current
- Page 174 and 175:
FC05 Translational science in the m
- Page 176 and 177:
FC05 Translational science in the m
- Page 178 and 179:
FC06 The heart gone wrong; stabiliz
- Page 180 and 181:
FC07 Simulation and data modelling
- Page 182 and 183:
FC08 Developments in the treatment
- Page 184 and 185:
FC09 Inflammation and immunopharmac
- Page 186 and 187:
FC09 Inflammation and immunopharmac
- Page 188 and 189:
FC09 Inflammation and immunopharmac
- Page 190 and 191:
FC13 Maximising benefits and minimi
- Page 192 and 193:
FC13 Maximising benefits and minimi
- Page 194 and 195:
W03 Targeting TRP channels for pain
- Page 196 and 197:
W19 Influence of degeneration and r
- Page 198 and 199:
W19 Influence of degeneration and r
- Page 200 and 201:
W20 Pharmacology education for a su
- Page 202 and 203:
FC01 Clinical pharmacology in the e
- Page 204 and 205:
FC02 Transmembrane transport: Persp
- Page 206 and 207:
FC02 Transmembrane transport: Persp
- Page 208 and 209:
FC04 Pharmacoepidemiology, current
- Page 210 and 211:
FC05 Translational science in the m
- Page 212 and 213:
FC05 Translational science in the m
- Page 214 and 215:
FC06 The heart gone wrong; stabiliz
- Page 216 and 217:
FC07 Simulation and data modelling
- Page 218 and 219:
FC08 Developments in the treatment
- Page 220 and 221:
FC09 Inflammation and immunopharmac
- Page 222 and 223:
FC09 Inflammation and immunopharmac
- Page 224 and 225:
FC09 Inflammation and immunopharmac
- Page 226 and 227:
FC13 Maximising benefits and minimi
- Page 228 and 229:
FC13 Maximising benefits and minimi
- Page 230 and 231:
FC19 General session Tue 361 Analge
- Page 232 and 233:
FC19 General session - Biologics Tu
- Page 234 and 235:
FC19 General session - Haematology
- Page 236 and 237:
FC19 General session - oncology Tue
- Page 238 and 239:
FC19 General session - oncology Tue
- Page 240 and 241:
FC19 General session - Toxicology T
- Page 242 and 243:
W02 Symposium on advances in GI pha
- Page 244 and 245:
W11 New opportunities in the pharma
- Page 246 and 247:
W23 Applying pharmacogenomics (PGX)
- Page 248 and 249:
FC10 Drugs for half the world: Paed
- Page 250 and 251:
FC11 G protein-coupled 7TM receptor
- Page 252 and 253:
FC11 G protein-coupled 7TM receptor
- Page 254 and 255:
FC12 Ion channelopathies: New windo
- Page 256 and 257:
FC13 Maximising benefits and minimi
- Page 258 and 259:
FC13 Maximising benefits and minimi
- Page 260 and 261:
FC14 Addiction and doping: Neurobio
- Page 262 and 263:
FC15 Endothelium in health and dise
- Page 264 and 265:
FC15 Endothelium in health and dise
- Page 266 and 267:
FC15 Endothelium in health and dise
- Page 268 and 269:
W30 Is eNOS Still a valid therapeut
- Page 270 and 271:
FC16 Natural products: Past and fut
- Page 272 and 273:
FC16 Natural products: Past and fut
- Page 274 and 275:
FC16 Natural products: Past and fut
- Page 276 and 277:
FC17 New approaches and targets in
- Page 278 and 279:
FC17 New approaches and targets in
- Page 280 and 281:
W34 State-of-the-art of basic and c
- Page 282 and 283:
FC10 Drugs for half the world: Paed
- Page 284 and 285:
FC11 G protein-coupled 7TM receptor
- Page 286 and 287:
FC11 G protein-coupled 7TM receptor
- Page 288 and 289:
FC11 G protein-coupled 7TM receptor
- Page 290 and 291:
FC13 Maximising benefits and minimi
- Page 292 and 293:
FC13 Maximising benefits and minimi
- Page 294 and 295:
W29 New horizons in therapeutic dru
- Page 296 and 297:
FC14 Addiction and doping: Neurobio
- Page 298 and 299:
FC15 Endothelium in health and dise
- Page 300 and 301:
FC15 Endothelium in health and dise
- Page 302 and 303:
FC15 Endothelium in health and dise
- Page 304 and 305:
FC16 Natural products: Past and fut
- Page 306 and 307:
FC16 Natural products: Past and fut
- Page 308 and 309:
FC16 Natural products: Past and fut
- Page 310 and 311:
FC16 Natural products: Past and fut
- Page 312 and 313:
FC17 New approaches and targets in
- Page 314 and 315:
FC18 Nuclear receptor targets for t
- Page 316 and 317:
314 Index Name Paper ref. Name Pape
- Page 318 and 319:
316 Index Name Paper ref. Name Pape
- Page 320 and 321: 318 Index Name Paper ref. Name Pape
- Page 322 and 323: 320 Index Name Paper ref. Name Pape
- Page 324 and 325: 322 Index Name Paper ref. Name Pape
- Page 326 and 327: 324 Index Name Paper ref. Name Pape
- Page 328 and 329: 326 Index Name Paper ref. Name Pape
- Page 330 and 331: 328 Index Name Paper ref. Name Pape
- Page 332 and 333: 330 Index Name Paper ref. Name Pape
- Page 334 and 335: 332 Index Name Paper ref. Name Pape
- Page 336 and 337: 334 Index Name Paper ref. Name Pape
- Page 338 and 339: 336 Index Name Paper ref. Name Pape
- Page 340 and 341: 338 Index Name Paper ref. Name Pape
- Page 342 and 343: 340 Index Name Paper ref. Name Pape
- Page 344 and 345: 342 Index Name Paper ref. Name Pape
- Page 346 and 347: 344 Index Name Paper ref. Name Pape
- Page 348 and 349: 346 Index Name Paper ref. Name Pape
- Page 350 and 351: 348 Index Name Paper ref. Name Pape
- Page 352 and 353: 350 Index Name Paper ref. Name Pape
- Page 354 and 355: 352 Index Name Paper ref. Name Pape
- Page 356 and 357: 354 Index Name Paper ref. Name Pape
- Page 358 and 359: 356 Index Name Paper ref. Name Pape
- Page 360 and 361: 358 Index Name Paper ref. Name Pape
- Page 362 and 363: 360 Index Name Paper ref. Name Pape
- Page 364 and 365: 362 Index Name Paper ref. Name Pape
- Page 366 and 367: 364 Index Name Paper ref. Name Pape
- Page 368 and 369: 366 Index Name Paper ref. Name Pape
- Page 372 and 373: 370 Index Name Paper ref. Name Pape
- Page 374 and 375: 372 Index Name Paper ref. Name Pape
- Page 376 and 377: 374 Index Name Paper ref. Name Pape
- Page 378 and 379: 376 Index Name Paper ref. Name Pape
- Page 380 and 381: 378 Index Name Paper ref. Name Pape
- Page 382 and 383: 380 Index Name Paper ref. Name Pape
- Page 384 and 385: 382 Notes Notes
- Page 386: Final Programme printed in Singapor